Registro:

Referencias:

• Chrousos, G.P., The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation (1995) N. Engl. J. Med, 332, pp. 1351-1362
• Cippitelli, M., Sica, A., Viggiano, V., Ye, J., Ghosh, P., Birrer, M.J., Young, H.A., Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun (1995) J. Biol. Chem, 270, pp. 12548-12556
• Ashwell, J.D., Lu, F.W., Vacchio, M.S., Glucocorticoids in T cell development and function (2000) Annu. Rev. Immunol, 18, pp. 309-345
• Cupps, T.R., Fauci, A.S., Corticosteroid-mediated immunoregulation in man (1982) Immunol. Rev, 65, pp. 133-155
• Kovalovsky, D., Paez Pereda, M., Sauer, J., Perez Castro, C., Nahmod, V.E., Stalla, G.K., Holsboer, F., Arzt, E., The Th1 and Th2 cytokines IFN-gamma and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: Involvement of IL-1 (1998) Eur. J. Immunol, 28, pp. 2075-2085
• Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O'Shea, J.J., Bornstein, S.R., Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells (2002) FASEB J, 16, pp. 61-71
• Laue, L., Kawai, S., Brandon, D.D., Brightwell, D., Barnes, K., Knazek, R.A., Loriaux, D.L., Chrousos, G.P., Receptor-mediated effects of glucocorticoids on inflammation: Enhancement of the inflammatory response with a glucocorticoid antagonist (1988) J. Steroid. Biochem, 29, pp. 591-598
• Boumpas, D.T., Chrousos, G.P., Wilder, R.L., Cupps, T.R., Balow, J.E., Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates (1993) Ann. Intern. Med, 119, pp. 1198-1208
• Giguere, V., Hollenberg, S.M., Rosenfeld, M.G., Evans, R.M., Functional domains of the human glucocorticoid receptor (1986) Cell, 46, pp. 645-652
• Nissen, R.M., Yamamoto, K.R., The glucocorticoid receptor inhibits NF-kappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain (2000) Genes Dev, 14, pp. 2314-2329
• Jonat, C., Rahmsdorf, H.J., Park, K.K., Cato, A.C., Gebel, S., Ponta, H., Herrlich, P., Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone (1990) Cell, 62, pp. 1189-1204
• Yang-Yen, H.F., Chambard, J.C., Sun, Y.L., Smeal, T., Schmidt, T.J., Drouin, J., Karin, M., Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction (1990) Cell, 62, pp. 1205-1215
• Schule, R., Rangarajan, P., Kliewer, S., Ransone, L.J., Bolado, J., Yang, N., Verma, I.M., Evans, R.M., Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor (1990) Cell, 62, pp. 1217-1226
• Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Van der Saag, P.T., Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids (1995) Mol. Endocrinol, 9, pp. 401-412
• Biola, A., Andreau, K., David, M., Sturm, M., Haake, M., Bertoglio, J., Pallardy, M., The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes (2000) FEBS Lett, 487, pp. 229-233
• De Bosscher, K., Vanden Berghe, W., Haegeman, G., Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: Negative interference of activated glucocorticoid receptor with transcription factors (2000) J. Neuroimmunol, 109, pp. 16-22
• De Bosscher, K., Vanden Berghe, W., Haegeman, G., The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: Molecular mechanisms for gene repression (2003) Endocr. Rev, 24, pp. 488-522
• Gottlicher, M., Heck, S., Herrlich, P., Transcriptional cross-talk, the second mode of steroid hormone receptor action (1998) J. Mol. Med, 76, pp. 480-489
• Reichardt, H.M., Tuckermann, J.P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., Schutz, G., Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor (2001) EMBO J, 20, pp. 7168-7173
• Scheinman, R.I., Gualberto, A., Jewell, C.M., Cidlowski, J.A., Baldwin Jr., A.S., Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors (1995) Mol. Cell. Biol, 15, pp. 943-953
• Adcock, I.M., Glucocorticoid-regulated transcription factors (2001) Pulm. Pharmacol. Ther, 14, pp. 211-219
• Helmberg, A., Auphan, N., Caelles, C., Karin, M., Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor (1995) EMBO J, 14, pp. 452-460
• Liden, J., Delaunay, F., Rafter, I., Gustafsson, J., Okret, S., A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation (1997) J. Biol. Chem, 272, pp. 21467-21472
• Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H.J., Herrlich, P., Cato, A.C., A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1 (1994) EMBO J, 13, pp. 4087-4095
• Tao, Y., Williams-Skipp, C., Scheinman, R.I., Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis (2001) J. Biol. Chem, 276, pp. 2329-2332
• Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., Glimcher, L.H., A novel transcription factor, T-bet, directs Th1 lineage commitment (2000) Cell, 100, pp. 655-669
• Szabo, S.J., Sullivan, B.M., Stemmann, C., Satoskar, A.R., Sleckman, B.P., Glimcher, L.H., Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells (2002) Science, 295, pp. 338-342
• Robinson, D.S., O'Garra, A., Further checkpoints in Th1 development (2002) Immunity, 16, pp. 755-758
• Young, H.A., Hardy, K.J., Interferon-gamma: Producer cells, activation stimuli, and molecular genetic regulation (1990) Pharmacol. Ther, 45, pp. 137-151
• Abbas, A.K., Murphy, K.M., Sher, A., Functional diversity of helper T lymphocytes (1996) Nature, 383, pp. 787-793
• Mosmann, T.R., Coffman, R.L., TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties (1989) Annu. Rev. Immunol, 7, pp. 145-173
• Lighvani, A.A., Frucht, D.M., Jankovic, D., Yamane, H., Aliberti, J., Hissong, B.D., Nguyen, B.V., Paul, W.E., T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells (2001) Proc. Natl. Acad. Sci. U. S. A, 98, pp. 15137-15142
• Mullen, A.C., High, F.A., Hutchins, A.S., Lee, H.W., Villarino, A.V., Livingston, D.M., Kung, A.L., Yang, S.Y., Role of T-bet in commitment of TH1 cells before IL-12-dependent selection (2001) Science, 292, pp. 1907-1910
• Afkarian, M., Sedy, J.R., Yang, J., Jacobson, N.G., Cereb, N., Yang, S.Y., Murphy, T.L., Murphy, K.M., T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells (2002) Nat. Immunol, 3, pp. 549-557
• Neurath, M.F., Weigmann, B., Finotto, S., Glickman, J., Nieuwenhuis, E., Iijima, H., Mizoguchi, A., Galle, P.R., The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease (2002) J. Exp. Med, 195, pp. 1129-1143
• Blotta, M.H., DeKruyff, R.H., Umetsu, D.T., Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes (1997) J. Immunol, 158, pp. 5589-5595
• Brinkmann, V., Kristofic, C., Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets (1995) J. Immunol, 155, pp. 3322-3328
• Visser, J., van Boxel-Dezaire, A., Methorst, D., Brunt, T., de Kloet, E.R., Nagelkerken, L., Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro (1998) Blood, 91, pp. 4255-4264
• Hu, X., Li, W.P., Meng, C., Ivashkiv, L.B., Inhibition of IFN-gamma signaling by glucocorticoids (2003) J. Immunol, 170, pp. 4833-4839
• Franchimont, D., Galon, J., Gadina, M., Visconti, R., Zhou, Y., Aringer, M., Frucht, D.M., O'Shea, J.J., Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes (2000) J. Immunol, 164, pp. 1768-1774
• Miyaura, H., Iwata, M., Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids (2002) J. Immunol, 168, pp. 1087-1094
• Boumpas, D.T., Paliogianni, F., Anastassiou, E.D., Balow, J.E., Glucocorticosteroid action on the immune system: Molecular and cellular aspects (1991) Clin. Exp. Rheumatol, 9, pp. 413-423
• Braun, C.M., Huang, S.K., Bashian, G.G., Kagey-Sobotka, A., Lichtenstein, L.M., Essayan, D.M., Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses (1997) J. Allergy Clin. Immunol, 100, pp. 400-407
• Raiden, S., Polack, E., Nahmod, V., Labeur, M., Holsboer, F., Arzt, E., TRH receptor on immune cells: In vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH (1995) J. Clin. Immunol, 15, pp. 242-249
• Siegel, M.D., Zhang, D.H., Ray, P., Ray, A., Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements (1995) J. Biol. Chem, 270, pp. 24548-24555
• Hwang, E.S., Choi, A., Ho, I.C., Transcriptional regulation of GATA-3 by an intronic regulatory region and fetal liver zinc finger protein 1 (2002) J. Immunol, 169, pp. 248-253
• Ouyang, W., Ranganath, S.H., Weindel, K., Bhattacharya, D., Murphy, T.L., Sha, W.C., Murphy, K.M., Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism (1998) Immunity, 9, pp. 745-755
• Klein-Hessling, S., Jha, M.K., Santner-Nanan, B., Berberich-Siebelt, F., Baumruker, T., Schimpl, A., Serfling, E., Protein kinase A regulates GATA-3-dependent activation of IL-5 gene expression in Th2 cells (2003) J. Immunol, 170, pp. 2956-2961
• Lee, H.J., Takemoto, N., Kurata, H., Kamogawa, Y., Miyatake, S., O'Garra, A., Arai, N., GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells (2000) J. Exp. Med, 192, pp. 105-115
• Lee, H.J., Masuda, E.S., Arai, N., Arai, K., Yokota, T., Definition of cis-regulatory elements of the mouse interleukin-5 gene promoter. Involvement of nuclear factor of activated T cell-related factors in interleukin-5 expression (1995) J. Biol. Chem, 270, pp. 17541-17550
• Fox, H.S., Bond, B.L., Parslow, T.G., Estrogen regulates the IFN-gamma promoter (1991) J. Immunol, 146, pp. 4362-4367
• Rupprecht, R., Arriza, J.L., Spengler, D., Reul, J.M., Evans, R.M., Holsboer, F., Damm, K., Transactivation and synergistic properties of the mineralocorticoid receptor: Relationship to the glucocorticoid receptor (1993) Mol. Endocrinol, 7, pp. 597-603
• McKean, D.J., Bell, M., Huntoon, C., Rastogi, S., Van Norstrand, M., Podzorski, R., Nilson, A., Paya, C., IL-1 receptor and TCR signals synergize to activate NF-kappa B-mediated gene transcription (1995) Int. Immunol, 7, pp. 9-20
• Hollenberg, S.M., Evans, R.M., Multiple and cooperative trans-activation domains of the human glucocorticoid receptor (1988) Cell, 55, pp. 899-906
• Paez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A.C., Hopfner, U., Grubler, Y., Chervin, A., Hentges, S.T., Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk (2003) Proc. Natl. Acad. Sci. U. S. A, 100, pp. 1034-1039
• Costas, M., Trapp, T., Pereda, M.P., Sauer, J., Rupprecht, R., Nahmod, V.E., Reul, J.M., Arzt, E., Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis (1996) J. Clin. Invest, 98, pp. 1409-1416
• Sakai, D.D., Helms, S., Carlstedt-Duke, J., Gustafsson, J.A., Rottman, F.M., Yamamoto, K.R., Hormone-mediated repression: A negative glucocorticoid response element from the bovine prolactin gene (1988) Genes Dev, 2, pp. 1144-1154
• Novac, N., Baus, D., Dostert, A., Heinzel, T., Competition between glucocorticoid receptor and NF-kappaB for control of the human FasL promoter (2006) FASEB J, 20, pp. 1074-1081
• Yudt, M.R., Jewell, C.M., Bienstock, R.J., Cidlowski, J.A., Molecular origins for the dominant negative function of human glucocorticoid receptor beta (2003) Mol. Cell. Biol, 23, pp. 4319-4330
• Yin, Z., Chen, C., Szabo, S.J., Glimcher, L.H., Ray, A., Craft, J., T-Bet expression and failure of GATA-3 cross-regulation lead to default production of IFN-gamma by gammadelta T cells (2002) J. Immunol, 168, pp. 1566-1571
• Cho, J.Y., Grigura, V., Murphy, T.L., Murphy, K., Identification of cooperative monomeric Brachyury sites conferring T-bet responsiveness to the proximal IFN-gamma promoter (2003) Int. Immunol, 15, pp. 1149-1160
• Hwang, E.S., Szabo, S.J., Schwartzberg, P.L., Glimcher, L.H., T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3 (2005) Science, 307, pp. 430-433
• Hwang, E.S., Hong, J.H., Glimcher, L.H., IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508 (2005) J. Exp. Med, 202, pp. 1289-1300
• Traenckner, E.B., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S., Baeuerle, P.A., Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli (1995) EMBO J, 14, pp. 2876-2883
• Auphan, N., DiDonato, J.A., Rosette, C., Helmberg, A., Karin, M., Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis (1995) Science, 270, pp. 286-290
• O'Shea, J.J., Park, H., Pesu, M., Borie, D., Changelian, P., New strategies for immunosuppression: Interfering with cytokines by targeting the Jak/Stat pathway (2005) Curr. Opin. Rheumatol, 17, pp. 305-311

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------